Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
Addressing the global mental health crisis requires collaboration across sectors and systems. This session explores how funders, researchers, clinicians, and communities can work together to build scalable, innovative models that close care gaps and improve access for all.
As the population ages, neurodegenerative diseases pose growing challenges—but advances in genetics, AI, and biomedical research offer new hope.
AI is transforming biomedical research, offering powerful tools to accelerate discovery. This session explores how to harness AI’s potential responsibly and equitably.
Ambitious, collaborative research has long driven major scientific breakthroughs. This panel explores how past successes can inspire the next era of discovery.
Computational biology is transforming disease research through data and AI. SPARC’s Giving Smarter Guide, developed with the Biswas Family Foundation, highlights how philanthropy can drive impact in this rapidly advancing field.
Sarcoidosis is a complex, often lifelong disease with limited treatment options and high costs for patients. To help address these challenges, the Ann Theodore Foundation partnered with SPARC to advance research and better support the sarcoidosis community.
This report examines the challenges of developing treatments for childhood cancers and showcases how collaboration across sectors can drive progress.
The Biswas Family Foundation, in partnership with SPARC, announced $14 million in grants to advance AI-driven research in clinical healthcare.
The Building the Mental Wealth of Nations forum held in Davos 2024 brought together luminaries from industry, science, health, technology, and economics to discuss the Mental Wealth of Nations.
To understand treatment practices for bipolar disorders, this study leveraged the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic treatment patterns in multiple cohorts of well-characterized individuals with BD.
BD² accelerates research-to-care translation so people with bipolar disorder can thrive. With over $60 million in funding, Dr. Cara Altimus, Dr. Emily Baxi, & Dr. Daniel Pham highlight how collaboration drives progress.
This report provides an overview of FTD research and funding patterns. It also identifies opportunities for philanthropists to invest in groundbreaking research to improve outcomes and quality of life for FTD patients.